Dance Biopharm Holdings takes in $20.5 mln
San Francisco-based Dance Biopharm Holdings Inc, a clinical-stage biopharma company, has raised about $20.5 million in funding. The investors included Molex Ventures LLC, a subsidiary of Koch Industries.
23 April 2019•1 min read
